Diabetologia

Papers
(The H4-Index of Diabetologia is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]581
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]298
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study238
Up Front230
58th EASD Annual Meeting of the European Association for the Study of Diabetes207
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory178
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes143
Ageing well with diabetes: the role of technology141
In Memoriam Werner Waldhäusl, 27 September 1937–22 May 2025137
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin135
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people134
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation130
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells114
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study103
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes94
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification90
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes89
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT88
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study81
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study78
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq78
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study76
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care73
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)68
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway68
60th EASD Annual Meeting of the European Association for the Study of Diabetes68
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo68
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy66
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities66
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study64
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials63
Pinpointing precision medicine for diabetes mellitus61
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications61
Mortality risk for kidney transplant candidates with diabetes: a population cohort study60
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults60
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk60
The role of automated insulin delivery technology in diabetes58
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women57
Up Front56
Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry56
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study56
Daniel Porte Jr, 13 August 1931–13 May 202355
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open55
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes55
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy55
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap54
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals53
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial53
Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics51
Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity51
Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial51
0.052812099456787